| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/27/2014 | US20140056842 Cellular therapeutic approaches to traumatic brain and spinal cord injury |
| 02/27/2014 | US20140056820 Transport agents for crossing the blood-brain and into brain cancer cells and methods of use thereof |
| 02/26/2014 | EP2700655A1 Surface-active collagen membrane by peptide |
| 02/26/2014 | EP2700654A1 Human insulin and analog conjugate thereof |
| 02/26/2014 | EP2700421A1 Immobilized biologically active entities having a high degree of biological activity |
| 02/26/2014 | EP2700409A1 IL-27 for modulation of immune response in acute lung disease |
| 02/26/2014 | EP2700399A1 Drug delivery particles and method for producing same |
| 02/26/2014 | EP2699678A1 Method for preparing a concentrate of factor xi |
| 02/26/2014 | EP2699677A1 Protein for use as a medicament |
| 02/26/2014 | EP2699676A1 Modified acid alpha glucosidase with accelerated processing |
| 02/26/2014 | EP2699595A1 Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity |
| 02/26/2014 | EP2699593A1 Beta-2 microglobulin-deficient cells |
| 02/26/2014 | EP2699592A2 Anticancer fusion protein |
| 02/26/2014 | EP2699591A1 Growth hormone releasing factor (grf) analogs and uses thereof |
| 02/26/2014 | EP2699265A1 STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc |
| 02/26/2014 | EP2699258A2 Aav mediated ctla-4 gene transfer to treat sjogren's syndrome |
| 02/26/2014 | EP2699254A1 A method of peptide hydrolysis, peptidase, the composition for use as a bacteriostatic and bactericidal agent, a kit and the uses of the active form of lytm from s. aureus or derivatives thereof |
| 02/26/2014 | EP2699253A2 Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria |
| 02/26/2014 | EP2699252A2 Method of drug delivery for pth, pthrp and related peptides |
| 02/26/2014 | EP2699251A1 Infant formula for use in the prevention of cardiovascular diseases |
| 02/26/2014 | EP2699249A1 Cartilage product |
| 02/26/2014 | EP2699231A1 Suspension type topical formulations comprising cyclic depsipeptide |
| 02/26/2014 | CN103608352A Method for producing protein preparation |
| 02/26/2014 | CN103608047A Hydrophobic polymer compound having anticoagulant effect |
| 02/26/2014 | CN103608031A Method for treating IFNalpha related conditions |
| 02/26/2014 | CN103608030A Compositions and methods for therapy and diagnosis of cancer |
| 02/26/2014 | CN103608029A Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-FU) and irinocetan (FOLFIRI) |
| 02/26/2014 | CN103608028A Human myeloid derived suppressor cell cancer markers |
| 02/26/2014 | CN103608027A Method for the generation of compact TALE-nucleases and uses thereof |
| 02/26/2014 | CN103608026A Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion |
| 02/26/2014 | CN103608003A A sustained-release composition containing a melanocortin receptor ligand as the active ingredient |
| 02/26/2014 | CN103602650A Treatment of pain by use of a single chain polypeptide fusion protein |
| 02/26/2014 | CN103601808A Novel natriuretic peptide, preparation method and applications thereof in preparation of genetic engineering drugs |
| 02/26/2014 | CN103601800A Mono- and di-PEG IL-10 production, and uses |
| 02/26/2014 | CN103601795A Scylla paramamosain anti-fungal anti-lipopolysaccharide factor, as well as preparation method and application thereof |
| 02/26/2014 | CN103601792A Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 02/26/2014 | CN103599541A Compositions and methods for the prevention of oxidative degradation of proteins |
| 02/26/2014 | CN103599535A External ointment prepared from i26 immune egg powder and traditional Chinese medicine decoction |
| 02/26/2014 | CN103599527A Pharmaceutical composition containing modified type human coagulation factor FVII-Fc fusion protein |
| 02/26/2014 | CN103599526A Pig broad spectrum immune enhancer and preparation method thereof |
| 02/26/2014 | CN103599525A Chelated calcium electuary |
| 02/26/2014 | CN103599524A Compound walnut powder solid preparation |
| 02/26/2014 | CN103599523A Application of pentapeptide metabolite in preparation of anti-inflammatory medicine |
| 02/26/2014 | CN103599522A Traditional Chinese medicine preparation for treating herpes zoster |
| 02/26/2014 | CN103599521A Vitamin D complex granules |
| 02/26/2014 | CN103599163A Medicine composition with anticancer effect |
| 02/26/2014 | CN103599072A Preparation method of polylactic-co-glycolic acid (PLGA) nano-particles encapsulated with nano insulin |
| 02/26/2014 | CN102949709B External gel used for treating diabetic foot, and preparation method and application thereof |
| 02/26/2014 | CN102823723B Nucleoside polypeptide composition as well as preparation method thereof and purpose thereof |
| 02/26/2014 | CN102813753B Composition containing Cistanche deserticola or Herba Cynomorii and combination of chrysanthemum, taurine, lycopene, xanthophyll and beta-carotene |
| 02/26/2014 | CN102807601B Aminoacyl-tryptophanyl-5-methoxytryptamine and preparation method and application thereof |
| 02/26/2014 | CN102796168B Compounds with thrombolytic activity and preparation method and application thereof |
| 02/26/2014 | CN102796165B Arg-Tyr modified aliphatic amine/ alcohol derivatives and preparation method and application thereof |
| 02/26/2014 | CN102732524B Use of histidine-rich glycoprotein (HRG)-like lampetra japonica Lj-RGD3 all RGD deletion mutant Lj-112 in antitumor drug |
| 02/26/2014 | CN102731630B Antioxidant oligopeptide with skin penetration capability |
| 02/26/2014 | CN102617727B Thymalfasin compound and novel preparation method thereof |
| 02/26/2014 | CN102481335B Stimulator of genital, sexual and reproductive function |
| 02/26/2014 | CN102357084B Enalapril maleate tablet composition and its preparation and use |
| 02/26/2014 | CN102344489B Modified sodium iodine symporter protein and application thereof |
| 02/26/2014 | CN102276698B MC4-R cyclopeptide agonist and application thereof |
| 02/26/2014 | CN102093475B Analogue of glucagon like peptide-1 |
| 02/26/2014 | CN101932592B Antitumoral compounds |
| 02/26/2014 | CN101677959B Slow release pharmaceutical composition made of microparticles |
| 02/26/2014 | CN101472603B Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene |
| 02/26/2014 | CN101003573B Human antibodies that bind human tnfalpha |
| 02/25/2014 | US8658767 Lipidated polyepitope vaccines |
| 02/25/2014 | US8658765 Non-natural MIC proteins |
| 02/25/2014 | US8658763 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 02/25/2014 | US8658762 Polypeptides that inhibit dopamine D2 receptor-DISC1 interaction and methods of use thereof |
| 02/25/2014 | US8658695 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 02/25/2014 | US8658607 Immunostimulatory G, U-containing oligoribonucleotides |
| 02/25/2014 | US8658604 Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity |
| 02/25/2014 | US8658603 Compositions and methods for inducing an immune response |
| 02/25/2014 | US8658602 Multimeric constructs |
| 02/25/2014 | US8658601 Peptides and nanoparticles for therapeutic and diagnostic applications |
| 02/25/2014 | US8658600 Antineoplastic hydrogels, and enzyme-instructed preparations thereof |
| 02/25/2014 | US8658599 Peptide for the prophylactic or therapeutic treatment of skin tumors in initial stages |
| 02/25/2014 | US8658598 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies |
| 02/25/2014 | US8658597 Stabilised compositions of factor VII polypeptides |
| 02/25/2014 | US8658596 Biglycan and related therapeutics and methods of use |
| 02/25/2014 | US8658594 Peptide inhibitors of protein kinase C |
| 02/25/2014 | US8658592 Biologically active peptides and their new uses |
| 02/25/2014 | US8658591 Multi-LEU peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents |
| 02/25/2014 | US8658373 Method of screening for an agent for treating arthritis and promoting growth of articular chondrocytes |
| 02/25/2014 | US8658218 Composition with anti-inflammatory, protein synthesizing, treatment of enzyme deficiency, activating genetic therapy and anti-cancer activity and methods of use |
| 02/25/2014 | US8658196 Graft materials and methods for staged delivery of bioactive components |
| 02/25/2014 | US8658179 Glycosylated specificity exchangers |
| 02/25/2014 | US8658176 Lipidated tumor-associated antigens and immunotherapeutic compositions |
| 02/25/2014 | US8658171 Humanized anti-TNFα antibodies |
| 02/25/2014 | US8658168 Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells |
| 02/25/2014 | US8658163 Compositions and use thereof for treating symptoms of preeclampsia |
| 02/25/2014 | US8658162 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| 02/25/2014 | US8658160 Composition and method for cancer chemoprevention |
| 02/25/2014 | US8658158 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 02/25/2014 | US8658135 Antagonists of ligands and uses thereof |
| 02/25/2014 | US8658128 System and method for diagnosis and treatment |
| 02/25/2014 | CA2720980C Methods for enhanced production of bone morphogenetic proteins |
| 02/25/2014 | CA2654446C Inhibitors of serine protease activity and their use in methods and compositions for treatment of graft rejection and promotion of graft survival |
| 02/25/2014 | CA2609271C Novel substrate for rpn 11 enzymatic activity |
| 02/25/2014 | CA2575926C Canine specific growth hormone releasing hormone |